GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
GenSight Biologics ($DE:G49N) announced an update on their ongoing clinical study. The REVISE study, officially titled “A Dose-ranging Randomized, Open-label Study Evaluating the Effect of Bilateral Intravitreal Injection of GS010
...Read more
G49N News on the Web
TipRanks News
Neutral
TipRanks News
Neutral
TipRanks News
Bullish
TipRanks News
Bearish
TipRanks News
Neutral
Simply Wall St
Bearish
TipRanks News
Neutral
Clinical Trials Arena
Neutral
News Score - Last 7 Days
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is DE:G49N’s Media Buzz Sentiment?
1 articles about DE:G49N were published this week. In an average week, 1 articles are published.
What is DE:G49N’s weekly average amount of articles?
In an average week, 1 articles about DE:G49N are published.
What is DE:G49N’s News Sentiment?
50% of articles about DE:G49N were positive this week, compared to its sector average of 68%.